Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan E Bates

Showing results (181-190 of 293) with videos related to

Pageof 30
Sort By:
Biochemistry|January 22, 2010
Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2Orsolya Polgar, Caterina Ierano, Akina Tamaki, et al.
Cell Cycle (Georgetown, Tex.)|August 23, 2013
Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitorsCaterina Ierano, Arup R Chakraborty, Alina Nicolae, et al.
Cancer Genetics and Cytogenetics|July 5, 2005
Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cellsV Koneti Rao, Darawalee Wangsa, Robert W Robey, et al.
The Annals of Pharmacotherapy|October 21, 2010
Induction of CYP3A4 by vinblastine: Role of the nuclear receptor NR1I2Nicola F Smith, Sridhar Mani, Erin G Schuetz, et al.
The Oncologist|October 8, 2008
Tumor growth rates derived from data for patients in a clinical trial correlate strongly with patient survival: a novel strategy for evaluation of clinical trial dataWilfred D Stein, William Doug Figg, William Dahut, et al.
Molecular Cancer Therapeutics|July 15, 2004
In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicitySusan D Mertins, Timothy G Myers, Susan L Holbeck, et al.
The Oncologist|April 3, 2023
A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid TumorsMeredith LaRose, Roisin M Connolly, Ciara C O'Sullivan, et al.
Biochemical Pharmacology|February 1, 2008
Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R))Robert W Robey, Suneet Shukla, Elizabeth M Finley, et al.
Cancer Research|June 18, 2003
Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecinRajeev Rajendra, Murugesan K Gounder, Ahamed Saleem, et al.
Cancer Research|June 3, 2005
Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2Abdelhakim Ahmed-Belkacem, Alexandre Pozza, Francisco Muñoz-Martínez, et al.
Pageof 30

Showing results (181-190 of 293) with videos related to

Sort By:
Pageof 30
Biochemistry|January 22, 2010
Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2Orsolya Polgar, Caterina Ierano, Akina Tamaki, et al.
Cell Cycle (Georgetown, Tex.)|August 23, 2013
Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitorsCaterina Ierano, Arup R Chakraborty, Alina Nicolae, et al.
Cancer Genetics and Cytogenetics|July 5, 2005
Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cellsV Koneti Rao, Darawalee Wangsa, Robert W Robey, et al.
The Annals of Pharmacotherapy|October 21, 2010
Induction of CYP3A4 by vinblastine: Role of the nuclear receptor NR1I2Nicola F Smith, Sridhar Mani, Erin G Schuetz, et al.
The Oncologist|October 8, 2008
Tumor growth rates derived from data for patients in a clinical trial correlate strongly with patient survival: a novel strategy for evaluation of clinical trial dataWilfred D Stein, William Doug Figg, William Dahut, et al.
Molecular Cancer Therapeutics|July 15, 2004
In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicitySusan D Mertins, Timothy G Myers, Susan L Holbeck, et al.
The Oncologist|April 3, 2023
A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid TumorsMeredith LaRose, Roisin M Connolly, Ciara C O'Sullivan, et al.
Biochemical Pharmacology|February 1, 2008
Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R))Robert W Robey, Suneet Shukla, Elizabeth M Finley, et al.
Cancer Research|June 18, 2003
Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecinRajeev Rajendra, Murugesan K Gounder, Ahamed Saleem, et al.
Cancer Research|June 3, 2005
Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2Abdelhakim Ahmed-Belkacem, Alexandre Pozza, Francisco Muñoz-Martínez, et al.
Pageof 30